Anupam Rasayan India Ltd
Anupam Rasayan India Q1 FY26 earnings call: Revenue & Margins
Q1 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹486Cr
- +91.3% YoY
- Net profit
- ₹48Cr
- +300% YoY
- Margin
- 26%
- +5 pp YoY
Guidance rank: #20 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
Anupam Rasayan India Ltd Q1 FY26 key numbers
- Revenue
- Letter of Intents (LOIs) contributing around INR 450-500 crores this year, expected to double compared to last year.
As stated in Anupam Rasayan India Ltd's Q1 FY26 earnings call transcript · published 5 Aug 2026. Reported figures, not investment advice.
The short version
Strong revenue growth expected in FY '26 and beyond, with overall growth of over 30% anticipated. Anupam Rasayan expects strong revenue growth of over 30% in FY '26 driven by all segments: agro, pharma, polymer, and personal care.
From Anupam Rasayan India Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Strong revenue growth expected in FY '26 and beyond, with overall growth of over 30% anticipated.
- Letter of Intents (LOIs) contributing around INR 450-500 crores this year, expected to double compared to last year.
- Similar growth trajectory expected next year as many LOIs and contracts get commercialized and ramped up.
- Pharma segment revenue grew 3x year-on-year, expected to continue strong growth supported by new molecule launches.
- Performance materials segment projected to grow from double-digit contribution to 15-20% in the current year, reaching 20-25% in next 2-3 years.
2 more points from Anupam Rasayan India Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Anupam Rasayan India Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- All planned capex projects have been completed, with plants commissioned and fully operational.
- Two new plants have been commercialized, and trial runs are ongoing in one additional plant.
- No major capex is planned or necessitated in the near term.
2 more points from Anupam Rasayan India Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Anupam Rasayan India Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Current order book stands at INR 14,646 crores, including recently signed LOIs with Japanese and U.S.-based multinational companies.
- LOIs largely cater to polymer (performance chemicals) and agrochemical segments.
- Expected order inflow for the current year is around INR 450-500 crores, with plans to double the LOI contribution compared to last year.
- Similar growth in LOI order book is expected next year as many contracts are commercializing and ramping up.
2 more points from Anupam Rasayan India Ltd's call on order book
Create a free account to keep reading this call
Anupam Rasayan India Ltd — Quarterly revenue & net profit
Anupam Rasayan India Ltd Q1 FY26 results — key figures
| ₹ Cr | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue | 486 | 254 | +91.3% | 500 | -2.8% |
| Operating profit (EBITDA) | 124 | 53 | +134% | 144 | -13.9% |
| Operating margin | 26% | 21% | +5 pp | 29% | -3 pp |
| Profit before tax | 63 | 16 | +293.8% | 88 | -28.4% |
| Net profit (PAT) | 48 | 12 | +300% | 63 | -23.8% |
| EPS (₹) | 3.10 | 0.36 | +761.1% | 4.05 | -23.5% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹636 Cr, net profit ₹56 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Anupam Rasayan India Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Balaji Amines (Q1 FY26)
Q1FY26 consolidated revenue from operations: ₹367 crore, up 2% quarter-on-quarter from ₹361 crore in Q4FY25, but down 7% year-on-year from ₹393 crore in Q1FY25…
- Linde India (Q1 FY26)
Net Revenue for FY ended Mar’25 was INR 24,854 million, down 10.2% (–2,833 million) YoY from INR 27,687 million. Key concall takeaways from Linde India Ltd's…
- Vidhi Specialty (Q1 FY26)
87.9 Crores . Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.
- Chemcon Speciality Chemicals (Q1 FY26)
Q1 FY26 revenue from operations: ₹53.5 Cr, up 18% YoY from ₹45.5 Cr in Q1 FY25 (Page 7 & 6). Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q1…
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Anupam Rasayan India Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Anupam Rasayan India Ltd Q1 FY26 results?
Strong revenue growth expected in FY '26 and beyond, with overall growth of over 30% anticipated. Anupam Rasayan expects strong revenue growth of over 30% in FY '26 driven by all segments: agro, pharma, polymer, and personal care.
What is Anupam Rasayan India Ltd share price analysis?
Anupam Rasayan India Ltd currently shows a neutral. The stock trades at a P/E of 81.4 with a market cap of ₹13,847 Cr. Investors should review the full earnings analysis for detailed insights.
Is Anupam Rasayan India Ltd planning capital expenditure?
All planned capex projects have been completed, with plants commissioned and fully operational.
Keep Anupam Rasayan India Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.